PREOPERATIVE EVALUATION OF MEDICALLY INTRACTABLE PARTIAL SEIZURES USING I-123 IOMAZENIL SPECT

被引：0

作者：

VENZ, S ^{[1
]}

CORDES, M ^{[1
]}

STRAUB, HB ^{[1
]}

HIERHOLZER, J ^{[1
]}

SCHRODER, R ^{[1
]}

RICHTER, W ^{[1
]}

SCHMITZ, B ^{[1
]}

MEENCKE, H ^{[1
]}

FELIX, R ^{[1
]}

机构：

[1] FREE UNIV BERLIN,KLINIKUM RUDOLF VIRCHOW W,NEUROL KLIN & POLIKLIN,D-13353 BERLIN,GERMANY

来源：

NUKLEARMEDIZIN | 1994年 / 33卷 / 05期

关键词：

FOCAL EPILEPSY; I-123-LOMAZENIL; VIDO EEG MONITORING; SPECT; MRI; EPILEPSY SURGERY;

D O I：

暂无

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

SPECT with the benzodiazepine receptor antagonist I-123-Iomazenil was performed in 33 patients with intractable partial seizures for pre-operative evaluation. The results combined with MRI and 99mTc-HMPAO-SPECT findings were com-pared with the video-assisted EEG monitoring (''gold standard'') which localised the focus in 25 patients. 11 patients underwent surgical resection of the epileptogenic area and became seizure-free for a period up to 13 months. The Iomazenil SPECT had a significantly higher sensitivity compared to 99mTc-HMPAO in the visualization of an epileptogenic area and should be regularly used in the diagnostic of medically intractable partial seizures.

引用

页码：189 / 193

页数：5

共 50 条

[11] BRAIN SPECT WITH I-123 IODOBENZAMIDE (IBZM) - ASPECTS OF SEMIQUANTITATIVE EVALUATION
MENZEL, C
GRUNWALD, F
KLEMM, E
BROICH, K
KASPER, S
REICHMANN, K
HOTZE, AL
BIERSACK, HJ
NUKLEARMEDIZIN, 1993, 32 (05) : 227 - 230
[12] VOLUME AND ACTIVITY QUANTITATION WITH I-123 SPECT
GILLAND, DR
JASZCZAK, RJ
TURKINGTON, TG
GREER, KL
COLEMAN, RE
JOURNAL OF NUCLEAR MEDICINE, 1994, 35 (10) : 1707 - 1713
[13] Experience with 123I-iomazenil SPECT in acute cerebral infarction
Müller, V
Saur, D
Klutmann, S
Weiller, C
Röther, J
Clausen, M
NUCLEAR MEDICINE COMMUNICATIONS, 2002, 23 (12) : 1191 - 1196
[14] Pharmacokinetic analysis of benzodiazepine receptor binding of [I-123]iomazenil in human brain
Ito, K
Momose, T
Kotaki, H
Kojima, Y
Yamamoto, K
Katashima, M
Sawada, Y
Sasaki, Y
Iga, T
PHARMACEUTICAL RESEARCH, 1997, 14 (08) : 999 - 1003
[15] Additional value of I-123 MIBG SPECT in neuroblastoma
Pirson, AS
Krug, B
Tuerlinckx, D
Lacrosse, M
Luyx, D
Vander Borght, T
CLINICAL NUCLEAR MEDICINE, 2005, 30 (02) : 100 - 101
[16] I-123 IMP SPECT FINDINGS IN MITOCHONDRIAL ENCEPHALOMYOPATHIES
FUJII, T
OKUNO, T
ITO, M
HATTORI, H
MUTOH, K
GO, T
SHIRASAKA, Y
SHIRAISHI, H
IWASAKI, Y
ASATO, R
BRAIN & DEVELOPMENT, 1995, 17 (02): : 89 - 94
[17] CORTICAL DYSPLASIA AS AN EPILEPTOGENIC FOCUS - REDUCED BINDING OF I-123 IOMAZENIL WITH NORMAL UPTAKE IN TC-99M-HMPAO SPECT
BARTENSTEIN, P
LEHMENKUHLER, C
SCIUK, J
SCHUIERER, G
NUKLEARMEDIZIN, 1992, 31 (04) : 142 - 144
[18] Iodine-123 iodobenzofuran (I-123 IBF) SPECT in patients with parkinsonism
Nakabeppu, Y
Nakajo, M
Mitsuda, M
Tsuchimochi, S
Tani, A
Osame, M
ANNALS OF NUCLEAR MEDICINE, 1999, 13 (06) : 447 - 452
[19] Iodine-123 iodobenzofuran (I-123 IBF) SPECT in patients with parkinsonism
Yoshiaki Nakabeppu
Masayuki Nakajo
Mitsuru Mitsuda
Shinsaku Tsuchimochi
Atsushi Tani
Mitsuhiro Osame
Annals of Nuclear Medicine, 1999, 13 : 447 - 452
[20] Assessment of outcome by EC/IC bypass with 123I-iomazenil brain SPECT
Makino, K
Kamiyama, H
Takamura, H
Gotoh, S
Kobayashi, N
ANNALS OF NUCLEAR MEDICINE, 1999, 13 (04) : 261 - 264

← 1 2 3 4 5 →